Results: Acute Myeloid Leukemia

Results from Abstracts

Pick one of the followings

*Some genes may be words of complete meaning. In any case, if present, they are relevant key words.

Legend:

***	p-value <= 0.001
**	p-value <= 0.01
*	p-value <= 0.05
n.s.	not significant

Top Ranked Genes, Molecules or Short Names*

Flt3 ***
Npm1 ***
Efs ***
Cr1 **
Hr **
Runx1 **
Cd34 **
Sct **
Idh2 **
Nrm **
Idh1 **
Dnmt3a *
Wt1 *
Tp53 *
Zrsr2 *
Cd33 *
Gab2 *
Jmjd1c *
Kit *
Clec12a *
Bcl2l1 *
Cux1 *
Bmp4 *
Tet2 *
Cebpa *
Mn1 *
Gata2 *
Mut *
Kat6a *
Rrm1 *
Kmt2a *
Impact *
Lilrb4 *
Srp72 *
Hoxa9 n.s.
Gfi1b n.s.
Runx1t1 n.s.
Bcl2 n.s.
Tpo n.s.
Cd38 n.s.
Bax n.s.
Cck n.s.
Sall4 n.s.
Gfi1 n.s.
Jak2 n.s.
Lyn n.s.
Cr2 n.s.
Asxl1 n.s.
Hcst n.s.
Myc n.s.
Kdm1a n.s.
Txnip n.s.
Irf8 n.s.
Myh11 n.s.
Mecom n.s.
Setd2 n.s.
Pik3r1 n.s.
Ptpn11 n.s.
Rag1 n.s.
Chd4 n.s.
Cbl n.s.
Cd19 n.s.
Nup98 n.s.
Cdk7 n.s.
Samhd1 n.s.
Sp1 n.s.
Rara n.s.
Cxcr4 n.s.
Ddx41 n.s.
Dot1l n.s.
Hif1a n.s.
Abcb1 n.s.
Cdk9 n.s.
Eln n.s.
Cbfa2t3 n.s.
Abl1 n.s.
Csf3r n.s.
Pml n.s.
Kmt2c n.s.
Cd1a n.s.
Rad50 n.s.
Men1 n.s.
Mcl1 n.s.
Fgf2 n.s.
Mvd n.s.
Etv6 n.s.
Hmgb1 n.s.
Cxcr2 n.s.
Ctla4 n.s.
Cd28 n.s.
Cd14 n.s.
Bid n.s.
Fto n.s.
Cga n.s.
Stat3 n.s.
Atf4 n.s.
Hdac1 n.s.
Tlr4 n.s.
Cd63 n.s.
Srsf2 n.s.

Top Ranked Key Phrases

Allogeneic hematopoietic stem cell transplantation ***
Secondary acute myeloid leukemia saml ***
Acute myeloid leukemia aml remains ***
Allogeneic hematopoietic cell transplantation hct ***
Acute myeloid leukemia aml cells ***
Acute myeloid leukemia aml patients ***
Allogeneic stem cell transplantation ***
Hematopoietic stem cell transplantation ***
Allogeneic hematopoietic cell transplantation ***
Acute myeloid leukemia cells ***
Acute myeloid leukemia aml ***
Acute promyelocytic leukemia apl ***
Leukemia stem cells lscs ***
Acute myeloid leukemia patients ***
Event free survival efs ***
Disease free survival dfs ***
Trans retinoic acid ***
Acute promyelocytic leukemia ***
Acute myeloid leukemia ***
Acute lymphoblastic leukemia ***
Chronic myeloid leukemia ***
Hematopoietic stem cells **
Measurable residual disease **
Leukemia free survival **
Tyrosine kinase inhibitors **
Minimal residual disease **
Leukemic stem cells **
Cell cycle arrest **
G0 g1 phase **
R r aml **
Bone marrow microenvironment **
Bone marrow bm **
Aml cell lines **
Myeloid sarcoma ms **
Disease free survival **
Independent prognostic factor **
Bone marrow samples **
Independent risk factor **
Complete remission cr **
Flt3 itd mutation **
Bone marrow failure **
Generation sequencing ngs **
Newly diagnosed aml **
Multivariate analysis showed **
Primary aml cells **
Overall survival os **
Myelodysplastic syndromes mds *
Flt3 itd mutations *
Independent prognostic factors *
Myelodysplastic syndrome mds *
Western blot analysis *
Non relapse mortality *
Median overall survival *
Low dose cytarabine *
Arsenic trioxide ato *
Relapsed refractory aml *
Complete remission cr1 *
Potential therapeutic target *
Intermediate risk aml *
Present study was *
Hematopoietic stem *
Novo aml patients *
Acute leukemia *
Older aml patients *
Allogeneic transplantation *
Nf Κb n.s.
95% confidence interval ci n.s.
Elderly aml patients n.s.
Cell lines n.s.
Dna damage n.s.
Hematopoietic cells n.s.
Leukemia cells n.s.
Cell survival n.s.
Cell cycle n.s.
Bone marrow n.s.
Myeloid neoplasms n.s.
Cell growth n.s.
Tumor suppressor n.s.
C kit n.s.
Childhood leukemia n.s.
Myelodysplastic syndromes n.s.

Top Ranked Mesh Terms

Diagnosis ***
Adolescent ***
Hematopoietic stem cell transplantation ***
Cell line tumor ***
Female ***
Antineoplastic combined chemotherapy protocols ***
Apoptosis ***
Aged ***
Humans ***
Male ***
Young adult ***
Mutation ***
Survival rate ***
Leukemia myeloid acute ***
Myelodysplastic syndromes ***
Middle aged ***
Treatment outcome ***
Antineoplastic agents ***
Prognosis ***
Cytarabine ***
Drug therapy ***
Cell proliferation ***
Mortality ***
Adult ***
Pathology ***
Retrospective studies ***
Genetics ***
Aged 80 and over ***
Child ***
Gene expression regulation leukemic ***
Bone marrow **
Remission induction **
Biomarkers tumor **
Disease-free survival **
Fms-like tyrosine kinase 3 **
Recurrence **
Metabolism **
Hl-60 cells **
Neoplasm residual **
Gene expression regulation neoplastic **
Child preschool **
Flow cytometry **
Mice **
Leukemia **
Signal transduction **
Micrornas **
Risk factors **
Drug resistance neoplasm **
Follow-up studies **
Transplantation homologous **
Translocation genetic **
Pharmacology **
Nuclear proteins **
Cell survival **
Neoplasm proteins **
Infant **
Cell differentiation **
Oncogene proteins fusion **
Xenograft model antitumor assays *
Chromosome aberrations *
Karyotype *
Kaplan-meier estimate *
Histone-lysine n-methyltransferase *
Protein kinase inhibitors *
Granulocyte colony-stimulating factor *
Hematologic neoplasms *
Fatal outcome *
Hematopoiesis *
Antimetabolites antineoplastic *
Dna methylation *
Core binding factor alpha 2 subunit *
Incidence *
Neoplastic stem cells *
Genetic predisposition to disease *
Myeloproliferative disorders *
Stem cell niche *
Cord blood stem cell transplantation *
Health resources *
Combined modality therapy *
Tumor stem cell assay *
Rituximab *
Leukemia megakaryoblastic acute *
Chromosome deletion *
Azacitidine *
Central nervous system diseases *
Stat5 transcription factor *
Antibiotic prophylaxis *
Leukemia myelomonocytic juvenile *
Multicenter studies as topic *
Opportunistic infections *
Myosin heavy chains *
Receptors antigen t-cell *
Zinc fingers *
Cell cycle *
Bortezomib *
Genomic instability *
Core binding factor beta subunit *
Gata2 transcription factor *
Leukemia myelomonocytic acute *
Isothiocyanates *

Top Ranked Mesh Terms (Symptoms)

Recurrence **
Neoplasm residual **
Translocation genetic **
Chromosome aberrations *
Genetic predisposition to disease *
Chromosome deletion *
Genomic instability *
Philadelphia chromosome *
Multiple organ failure *
Abnormal karyotype *
Leukemic infiltration *
Disease progression *
Neovascularization pathologic *
Neoplasm recurrence local n.s.
Blast crisis n.s.
Cell transformation neoplastic n.s.
Acute disease n.s.
Bacteremia n.s.
Trisomy n.s.
Inflammation n.s.
Disease susceptibility n.s.
Chromosome inversion n.s.
Carcinogenesis n.s.
Hearing loss n.s.
Cross infection n.s.
Hearing disorders n.s.
Uniparental disomy n.s.
Abscess n.s.
Diseases in twins n.s.
Leukocytosis n.s.
Hyperplasia n.s.
Cardiotoxicity n.s.
Retinal hemorrhage n.s.
Monosomy n.s.
Shock septic n.s.
Cerebral hemorrhage n.s.
Psychomotor disorders n.s.
Sarcopenia n.s.
Fever n.s.
Rare diseases n.s.
Syndrome n.s.
Tetraploidy n.s.
Hemorrhage n.s.
Sepsis n.s.
Neoplasm invasiveness n.s.
Chronic disease n.s.

Results for: Acute Myeloid Leukemia

Results from Abstracts

KEGG Pathways

Gene Ontology Biological Processes